Tamifit-75 Capsules

Tamifit-75 Oseltamivir 75 mg Capsules

Tamifit-75 is an oral antiviral formulation containing Oseltamivir 75 mg. Oseltamivir belongs to the neuraminidase inhibitor class of antiviral medicines and is used in the management of influenza caused by susceptible influenza viruses.

Oseltamivir works by inhibiting influenza virus neuraminidase, an enzyme that plays an important role in the release of newly formed virus particles from infected cells. By interfering with this process, Oseltamivir helps limit the spread of influenza virus within the body.

Tamifit-75 may be used for the treatment of acute uncomplicated influenza and, when clinically appropriate, for prevention of influenza following exposure to an infected individual.

Composition

Oseltamivir Phosphate equivalent to Oseltamivir 75 mg

Uses of Tamifit-75 Capsules

Tamifit-75 may be prescribed for:

• Treatment of influenza
• Acute uncomplicated influenza
• Influenza A infection
• Influenza B infection
• Prevention of influenza following exposure to an infected person
• Influenza prophylaxis in selected individuals at risk of infection

Antiviral treatment is generally most beneficial when started early after the onset of influenza symptoms. The decision to use antiviral therapy should be made by a qualified healthcare professional based on the patient's clinical condition.

How Tamifit-75 Works

Oseltamivir is converted in the body to its active form, which inhibits influenza virus neuraminidase.

Neuraminidase is required for the release of newly formed influenza virus particles from infected cells. Inhibition of this enzyme reduces the spread of virus particles and helps limit viral replication.

Key Product Features

• Oseltamivir 75 mg
• Oral antiviral formulation
• Neuraminidase inhibitor
• Used for influenza treatment
• May be used for influenza prophylaxis when clinically indicated
• Active against susceptible Influenza A and Influenza B viruses
• Capsule dosage form
• 10 x 1 x 10 capsules packing

Product Information

Brand Name: Tamifit-75

Composition: Oseltamivir Phosphate equivalent to Oseltamivir 75 mg

Dosage Form: Capsules

Route of Administration: Oral

Therapeutic Class: Antiviral

Pharmacological Class: Influenza Neuraminidase Inhibitor

Packing: 10 x 1 x 10 Capsules

Important Information

Tamifit-75 is a prescription antiviral medicine and should be used under the supervision of a qualified healthcare professional.

It is intended for influenza and should not be used as a treatment for infections caused by bacteria.

Antiviral treatment generally provides the greatest benefit when initiated early after influenza symptoms begin. Medical evaluation is recommended, particularly for patients with severe, worsening or complicated symptoms.

Tamifit-75 should be used exactly as prescribed. Do not change the dose or duration of treatment without medical advice.

Patients with a known serious hypersensitivity to Oseltamivir or any component of the formulation should not use the medicine.

Patients with kidney impairment may require dosage adjustment. The prescribing healthcare professional should be informed about existing kidney disease or other relevant medical conditions.

Common adverse effects reported with Oseltamivir include nausea and vomiting. Other adverse effects may occur.

If severe allergic reactions, serious skin reactions, unusual behavioural changes or other concerning symptoms occur, seek immediate medical attention.

Dosage and Administration

The dosage and duration of treatment should be determined by the prescribing healthcare professional.

For adults and adolescents, the commonly recommended treatment regimen for influenza is 75 mg twice daily for 5 days, but the appropriate dose may vary depending on age, kidney function and clinical circumstances.

For influenza prophylaxis, dosing and duration differ from treatment and should be determined by a healthcare professional.

Do not self-medicate with antiviral medicines.

Storage

Store according to the storage conditions specified on the approved product label.

Keep the capsules in their original packaging.

Protect from excessive heat, moisture and direct light where applicable.

Keep out of reach of children.

Product Summary

Tamifit-75 contains Oseltamivir 75 mg, an influenza antiviral that acts by inhibiting viral neuraminidase.

It is used under medical supervision for the treatment of influenza and may also be prescribed for influenza prophylaxis following exposure. Early initiation of antiviral therapy is generally important for achieving the greatest clinical benefit.